ProPhase Labs Stock Forecast - Period Momentum Indicator
| PRPH Stock | USD 0.64 0.01 1.59% |
ProPhase Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of ProPhase Labs' historical fundamentals, such as revenue growth or operating cash flow patterns.
ProPhase |
| Previous Period Momentum Indicator | Period Momentum Indicator | Trend |
| 0.01 | (0.02) |
| Check ProPhase Labs Volatility | Backtest ProPhase Labs | Trend Details |
ProPhase Labs Trading Date Momentum
| On December 29 2024 ProPhase Labs was traded for 0.64 at the closing time. The top price for the day was 0.67 and the lowest listed price was 0.62 . There was no trading activity during the period 0.0. Lack of trading volume on December 29, 2024 did not cause price change. The trading delta at closing time against the current closing price is 3.13% . |
Generally speaking extended values of the momentum indicator over time are good indicators of oversold or over brought conditions.
| Compare ProPhase Labs to competition |
Other Forecasting Options for ProPhase Labs
For every potential investor in ProPhase, whether a beginner or expert, ProPhase Labs' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. ProPhase Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in ProPhase. Basic forecasting techniques help filter out the noise by identifying ProPhase Labs' price trends.ProPhase Labs Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ProPhase Labs stock to make a market-neutral strategy. Peer analysis of ProPhase Labs could also be used in its relative valuation, which is a method of valuing ProPhase Labs by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
ProPhase Labs Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of ProPhase Labs' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of ProPhase Labs' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
ProPhase Labs Market Strength Events
Market strength indicators help investors to evaluate how ProPhase Labs stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ProPhase Labs shares will generate the highest return on investment. By undertsting and applying ProPhase Labs stock market strength indicators, traders can identify ProPhase Labs entry and exit signals to maximize returns.
| Accumulation Distribution | 0.0746 | |||
| Daily Balance Of Power | 0.2 | |||
| Rate Of Daily Change | 1.02 | |||
| Day Median Price | 0.65 | |||
| Day Typical Price | 0.64 | |||
| Market Facilitation Index | 0.05 | |||
| Period Momentum Indicator | 0.01 |
ProPhase Labs Risk Indicators
The analysis of ProPhase Labs' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in ProPhase Labs' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting prophase stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.35 | |||
| Standard Deviation | 7.44 | |||
| Variance | 55.35 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
When determining whether ProPhase Labs offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ProPhase Labs' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Prophase Labs Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Prophase Labs Stock:Check out Historical Fundamental Analysis of ProPhase Labs to cross-verify your projections. For more detail on how to invest in ProPhase Stock please use our How to Invest in ProPhase Labs guide.You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProPhase Labs. If investors know ProPhase will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProPhase Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.95) | Earnings Share (1.53) | Revenue Per Share 0.996 | Quarterly Revenue Growth (0.81) | Return On Assets (0.23) |
The market value of ProPhase Labs is measured differently than its book value, which is the value of ProPhase that is recorded on the company's balance sheet. Investors also form their own opinion of ProPhase Labs' value that differs from its market value or its book value, called intrinsic value, which is ProPhase Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProPhase Labs' market value can be influenced by many factors that don't directly affect ProPhase Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProPhase Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if ProPhase Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProPhase Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.